“Costs and Efficacy Ofolanzapine and Risperidone in Schizophrenia”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 8, no. 2, June 2007, pp. 53-60, https://doi.org/10.7175/fe.v8i2.241.